BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of bis(methoxy methyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolines as EGFR tyrosine kinase inhibitors. 2005

Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
College of Pharmacy, Kyung Hee University, Seoul, Korea. ljy@khu.ac.kr

A series of 7,8-bis(methoxymethyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolines were prepared and evaluated for their inhibition of phosphorylation of the isolated epidermal growth factor receptor (EGFR) enzyme and for their growth inhibition of the A431 cell line. Among them, compound 3c having a 3-iodophenyl ring was most potent (IC(50) = 1.66 nM) against the isolated EGFR enzyme and also showed meaningful potency (GI(50) = 1.99 microM) against the A431 cell line, although less than PD153035 (GI(50) = 1.03 microM). However, compound 3e as the exact rigidified analogue of Erlotinib (Tarceva) was inferior to the original compound when compared to its reported data.

UI MeSH Term Description Entries
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045325 HCT116 Cells Human COLORECTAL CARCINOMA cell line. HCT 116 Cells,HCT-116 Cells,Cell, HCT 116,Cell, HCT-116,Cell, HCT116,Cells, HCT 116,Cells, HCT-116,Cells, HCT116,HCT 116 Cell,HCT-116 Cell,HCT116 Cell
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory
D066246 ErbB Receptors A family of structurally related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS. EGF Receptor,Epidermal Growth Factor Receptor,Epidermal Growth Factor Receptor Family Protein,Epidermal Growth Factor Receptor Protein-Tyrosine Kinase,ErbB Receptor,HER Family Receptor,Receptor, EGF,Receptor, Epidermal Growth Factor,Receptor, TGF-alpha,Receptor, Transforming-Growth Factor alpha,Receptor, Urogastrone,Receptors, Epidermal Growth Factor-Urogastrone,TGF-alpha Receptor,Transforming Growth Factor alpha Receptor,Urogastrone Receptor,c-erbB-1 Protein,erbB-1 Proto-Oncogene Protein,EGF Receptors,Epidermal Growth Factor Receptor Family Proteins,Epidermal Growth Factor Receptor Kinase,HER Family Receptors,Proto-oncogene c-ErbB-1 Protein,Receptor Tyrosine-protein Kinase erbB-1,Receptor, ErbB-1,Receptors, Epidermal Growth Factor,Epidermal Growth Factor Receptor Protein Tyrosine Kinase,ErbB-1 Receptor,Family Receptor, HER,Family Receptors, HER,Proto oncogene c ErbB 1 Protein,Proto-Oncogene Protein, erbB-1,Receptor Tyrosine protein Kinase erbB 1,Receptor, ErbB,Receptor, ErbB 1,Receptor, HER Family,Receptor, TGF alpha,Receptor, Transforming Growth Factor alpha,Receptors, EGF,Receptors, Epidermal Growth Factor Urogastrone,Receptors, ErbB,Receptors, HER Family,c erbB 1 Protein,c-ErbB-1 Protein, Proto-oncogene,erbB 1 Proto Oncogene Protein

Related Publications

Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Design, synthesis and biological evaluation of 2,3-dihydro-[1,4]dioxino[2,3-f]quinazoline derivatives as EGFR inhibitors.
May 2021, Bioorganic chemistry,
Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents.
February 2017, Bioorganic & medicinal chemistry,
Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Synthesis of novel 2,3-dihydro-1,4-dioxino[2,3-g]quinoline derivatives as potential antitumor agents.
March 2004, Bioorganic & medicinal chemistry,
Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Synthesis of 2-substituted-2,3- dihydro-1,4-dioxino[2,3-b]pyridine derivatives.
June 2000, Organic letters,
Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Synthesis of quinazolines as tyrosine kinase inhibitors.
March 2009, Anti-cancer agents in medicinal chemistry,
Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling.
May 2022, ACS omega,
Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Design, synthesis and biological evaluation of novel 3,4-dihydro-2H-[1,4]oxazino [2,3-f]quinazolin derivatives as EGFR-TKIs.
January 2023, Bioorganic & medicinal chemistry letters,
Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Novel substituted quinazolines for potent EGFR tyrosine kinase inhibitors.
January 2011, Current medicinal chemistry,
Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Biomass-involved synthesis of N-substituted benzofuro[2,3-d]pyrimidine-4-amines and biological evaluation as novel EGFR tyrosine kinase inhibitors.
June 2017, Organic & biomolecular chemistry,
Yong Sup Lee, and Seon Hee Seo, and Beom-Seok Yang, and Jae Yeol Lee
Synthesis of 5-substituted-2,3-dihydro-1,4-benzoxathiins: biological evaluation as melatonin receptors ligands.
April 2003, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!